Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Vital KSK Holdings's Enterprise Value is €327 Mil.
Vital KSK Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was €66 Mil. Therefore, Vital KSK Holdings's EV-to-EBIT ratio for today is 4.97.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Vital KSK Holdings's Enterprise Value is €327 Mil.
Vital KSK Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was €88 Mil. Therefore, Vital KSK Holdings's EV-to-EBITDA ratio for today is 3.70.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Vital KSK Holdings's Enterprise Value is €327 Mil.
Vital KSK Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was €3,461 Mil. Therefore, Vital KSK Holdings's EV-to-Revenue ratio for today is 0.09.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Vital KSK Holdings (FRA:4GX) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Vital KSK Holdings's current Enterprise Value is €327 Mil.
Vital KSK Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €66 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Vital KSK Holdings's current Enterprise Value is €327 Mil.
Vital KSK Holdings's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €88 Mil.
Vital KSK Holdings's current Enterprise Value is €327 Mil.
Vital KSK Holdings's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3,461 Mil.
Vital KSK Holdings's current Enterprise Value is €327 Mil.
Vital KSK Holdings's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.
Vital KSK Holdings's current Enterprise Value is €327 Mil.
Vital KSK Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vital KSK Holdings Enterprise Value Related Terms
Vital KSK Holdings Enterprise Value Historical Data
* Premium members only.
The historical data trend for Vital KSK Holdings's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:4GX vs MCK, CAH, COR: Enterprise Value Comparison
For the Medical Distribution subindustry, Vital KSK Holdings's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vital KSK Holdings Enterprise Value vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Vital KSK Holdings's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Vital KSK Holdings's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Vital KSK Holdings's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vital KSK Holdings (FRA:4GX) has a Enterprise Value of €327 Mil as of Jul. 12, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Vital KSK Holdings and its competitors.
Is Vital KSK Holdings' Enterprise Value too high?
Vital KSK Holdings' current Enterprise Value is €327 Mil. Overall, Vital KSK Holdings has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Vital KSK Holdings' Enterprise Value compare to MCK and CAH?
Vital KSK Holdings' Enterprise Value of €327 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Medical Distribution company?
A good Enterprise Value depends on the Medical Distribution industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Vital KSK Holdings and its competitors. Vital KSK Holdings's current Enterprise Value is €327 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vital KSK Holdings stock overvalued right now?
Vital KSK Holdings (FRA:4GX) has a current Enterprise Value of €327 Mil. The stock's GF Value™ is €7.05, compared to a current price of €8.30 — trading 17.7% above its estimated fair value. The current Enterprise Value is €327 Mil. Vital KSK Holdings' overall GF Score™ is 70/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Vital KSK Holdings (FRA:4GX), the current Enterprise Value is €327 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vital KSK Holdings (FRA:4GX) Overvalued in 2026?
Based on GuruFocus' analysis, Vital KSK Holdings stock appears to be overvalued.
The current stock price of €8.30 is trading 17.7% above its estimated GF Value™ of €7.05.
Key valuation signals for FRA:4GX:
Enterprise Value: €327 Mil
GF Value™: €7.05 vs. price of €8.30 (17.7% above fair value)
No single metric tells the full story. See the FRA:4GX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.
70GF Score
Get the complete analysis for FRA:4GX
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:4GX has been successfully added to your 
